Jones Financial Companies
IMVT icon

Jones Financial Companies’s Immunovant IMVT Stock Holding History

Jones Financial Companies’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$99.8K Buy
2,569
+1,088
+73% +$33.1K ﹤0.01% 2855
2026
Q1 		$35.5K Buy
1,481
+1,108
+297% +$28.7K ﹤0.01% 3072
2025
Q4 		$9.48K Buy
373
+320
+604% +$7.14K ﹤0.01% 3243
2025
Q3 		$860 Hold
53
– – ﹤0.01% 3932
2025
Q2 		$853 Buy
+53
New +$801 ﹤0.01% 3691

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jones Financial Companies's IMVT Position: Q2 2026 in Review

Jones Financial Companies increased its Immunovant (IMVT) stake by 73% in Q2 2026, buying an estimated $33.1K and bringing the position to 2,569 shares worth $99.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2855.

Jones Financial Companies first reported a position in IMVT in Q2 2025 and has held it in 5 quarters since. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Jones Financial Companies held 2,569 shares of Immunovant worth $99.8K as of Q2 2026.
  • Jones Financial Companies bought 1,088 Immunovant shares in Q2 2026, an estimated $33.1K.
  • Immunovant made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #2855 holding.
  • Jones Financial Companies first reported a position in Immunovant in Q2 2025 and has held it in 5 quarters since.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.